Metastatic lung non-squamous non-small cell carcinoma
Clinical trials for Metastatic lung non-squamous non-small cell carcinoma explained in plain language.
Never miss a new study
Get alerted when new Metastatic lung non-squamous non-small cell carcinoma trials appear
Sign up with your email to follow new studies for Metastatic lung non-squamous non-small cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise in lung cancer battle
Disease control OngoingThis study tests two new treatments—cabozantinib alone or with nivolumab—against standard chemotherapy for people with advanced non-squamous lung cancer that has returned. The goal is to see if these combinations can slow cancer growth better than current options. About 117 adult…
Matched conditions: METASTATIC LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New combo aims to control lung cancer when immunotherapy fails
Disease control OngoingThis phase 2 study tests a new drug (pevonedistat) combined with two standard chemotherapies (carboplatin and paclitaxel) in 27 adults with advanced non-small cell lung cancer that has not responded to immunotherapy. The goal is to see if this combination can shrink or control th…
Matched conditions: METASTATIC LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC